Table 2. Quantitative ECG measurements in T.cruzi seropositive and seronegative subjects.
ECG variable | Seropositive | Seronegative | p- value* |
N = 499 | N = 488 | ||
Heart Rate (bpm) | 62 (57–69) | 64 (58–72) | 0.003 |
PR duration (ms) | 160 (144–178) | 156 (142–168) | 0.007 |
QRS duration (ms) | 90 (84–104) | 88 (82–95,75) | <0.001 |
QT duration (ms) | 420 (402–439) | 412 (392–432) | <0.001 |
QTc duration (ms) | 429 (412–447) | 427 (411–442) | 0.061 |
HRV sdnn (ms) ** | 16 (10–25) | 22 (14–35) | <0.001 |
HRV rmssd (ms) ** | 18 (11–29) | 24 (15–39) | <0.001 |
Data is presented as median (interquartile range).
Reported if <0.05.
HRV data available in 467 seropositive and 458 seronegative subjects. QTc: corrected QT interval by Bazett's formula; HRV: heart rate variability; rmssd: root mean square of successive differences in normal RR intervals; sdnn: standard deviation of all normal RR intervals.